Followers | 65 |
Posts | 4647 |
Boards Moderated | 0 |
Alias Born | 02/12/2013 |
Tuesday, November 17, 2020 8:29:17 AM
GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. We have helped Americans save over $20 billion since 2011 and are the #1 most downloaded medical app in the last three years.
Recent GDRX News
- Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 05/03/2024 09:45:00 AM
- GoodRx Announces Date for 2024 Investor Day • Business Wire • 04/24/2024 12:00:00 PM
- GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/11/2024 08:09:00 PM
- GoodRx Interim CEO Extends Commitment to Company • Business Wire • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:15:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:20:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:00:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 07:37:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 07:04:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:12:19 AM
- GoodRx Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/29/2024 11:02:00 AM
- GoodRx to Participate in Upcoming Investor Conferences • Business Wire • 02/20/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:54:55 PM
- GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • Business Wire • 02/01/2024 09:05:00 PM
- GoodRx Announces Proposed Refinancing of First Lien Credit Facilities • Business Wire • 01/22/2024 07:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 08:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:00:56 PM
- The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings • Business Wire • 01/11/2024 02:00:00 PM
- GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024 • Business Wire • 01/10/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 02:06:27 PM
- GoodRx Appoints Kelly J. Kennedy to Board of Directors • Business Wire • 12/22/2023 02:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM